| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6790339 | European Neuropsychopharmacology | 2018 | 12 Pages |
Abstract
Specific monoamine CSF biomarkers may be related to the pathophysiology of BD. Future studies must aim at increasing the level of evidence by validating the positive findings in prospective studies with stringent methodology.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Ulla Knorr, Anja Hviid Simonsen, Henrik Zetterberg, Kaj Blennow, Steen Gregers Hasselbalch, Lars Vedel Kessing,